ASCO’s Leadership Development Program (LDP) prepares you to become a leader while giving you exclusive access to ASCO leaders and the broader oncology community, as well as a robust network of past ...

The budget reconciliation bill, known as the One Big Beautiful Bill (OBBB), a broad spending and tax bill that includes significant healthcare policies, is now on its way to President Trump after ...

With the exception of reducing the scope of claims subject to prior authorization and expanding real-time responses, CMS finalized requirements to implement these commitments in its final ruleson ...

Additionally, CMS announced it plans to complete all RADV audits for payment years 2019 through 2024 by early 2026. To complete both the old and new audits, CMS will use “enhanced technology,” such as ...

On June 20, 2025, the Centers for Medicare & Medicaid Services (CMS) released the 2025 Marketplace Integrity and Affordability final rule aimed at addressing improper enrollments in the ACA Health ...

A new article in JCO Oncology Practice (JCO OP) looks at the root causes of cancer drug shortages in the United States (U.S.), the impact of these shortages on patients and providers, and makes ...

While federal prior authorization reform legislation has yet to make it over the finish line and be enacted into law, state governments continue to pass legislation to mitigate the burdensome ...

Decentralized clinical trial elements can be safely adopted as permanent fixtures without substantial reductions in data quality or increased risk to research participants, according to a new study in ...

CHICAGO — Results from the international phase 3 AMPLITUDE clinical trial found that adding niraparib to abiraterone acetate (AKEEGA™) plus prednisone (AAP) can help slow cancer growth for people with ...

The current first-line treatment for people with locally advanced or metastatic HER2-positive breast cancer is a taxane given in combination with the HER2-targeted therapy drugs trastuzumab ...

CHICAGO — New study results show that a structured exercise program following surgery and adjuvant chemotherapy reduced the risk of recurrent or new cancer and increased survival for patients with ...